Metastasis-associated in colon cancer 1 and its role in cancer

doi:10.3760/cma.j.issn.1673-422X.2016.01.009

Abstract

Abstract: The protein product of metastasis-associated in colon cancer 1 (MACC1) gene induces the activation of hepatocyte growth factor/mesenchymalepithelial transition factor (HGF/c-Met) signaling pathway through transcriptionally activating cMet gene and upregulating its expression to further promote tumor invasion and metastasis. High level expression of MACC1 is associated with the occurrence and metastasis of a wide variety of human tumors, such as colon cancer, gastric cancer, liver cancer, lung cancer, ovarian cancer etc. In addition, the overexpression of MACC1 is also closely associated with clinical TNM stages and distant metastasis. Thus, MACC1 can serve as an independent indicator of tumor metastasis and prognosis, and become a new target for gene therapy.

Key words: Colonic neoplasms, Metastasis-associated in colon cancer 1, Proto-oncogene proteins c-Met

Guo Hongyan, He Lizhen, Zhang Yunfei, Zhang Hong, Jin Huiqin, An Wenwen. Metastasis-associated in colon cancer 1 and its role in cancer[J]. Journal of International Oncology, 2016, 43(1): 32-35.

References

［1］ Stein U, Walther W, Arlt F, et al. MACC1, a newly identified key regulator of HGFMET signaling, predicts colon cancer metastasis［J］. Nat Med, 2009, 15(1): 59-67. DOI:10.1038/nm.1889. ［2］ Stein U, Dahlmann M, Walther W. MACC1 more than metastasis? Facts and predictions about a novel gene［J］. J Mol Med, 2010, 88(1): 11-18. DOI:10.1007/s00109-009-0537-1. ［3］刘清泉, 刘青光, 昝献峰, 等. MACC1基因在肝细胞癌中的表达及临床意义［J］. 华中科技大学学报: 医学版, 2010, 39(1): 22-28. DOI:10.3870/j.issn.1672-0741.2010.01.006. ［4］ Yao Y, Dou C, Lu Z, et al. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/cMET/AKT pathway［J］. Cell Physiol Biochem, 2015, 35(3): 983996. DOI:10.1159/000369754. ［5］ Juneja M, Ilm K, Schlaga PM, et al. Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer［J］. Mol Oncol, 2013, 7(5): 929-943. DOI:10.1016/j.molonc.2013.05.003. ［6］ Stein U, Smith J, Walther W, et al. MACC1 controls Met: what a difference an Sp1 site makes［J］. Cell Cycle, 2009, 8(15): 2467-2469. ［7］ Skead G, Govender D. Gene of the month: MET［J］. J Clin Pathol, 2015, 68(6): 405-409. DOI:10.1136/jclinpath2015-203050. ［8］ Zlobec I. Novel biomarkers for the prediction of metastasis in colorectal cancer［J］. Expert Opin Med Diagn, 2013, 7(2): 137-146. DOI:10.1517/17530059.2013.753054. ［9］ Ren B, Zakharov V, Yang Q, et al. MACC1 is related to colorectal cancer initiation and earlystage invasive growth［J］. Am J Clin Pathol, 2013, 140(5): 701-707. DOI:10.1309/AJCPRH1H5RWWSXRB. ［10］ Sueta A, Yamamoto Y, YamamotoIbusuki M, et al. Differential role of MACC1 expression and its regulation of the HGF/c-Met pathway between breast and colorectal cancer［J］. Int J Oncol, 2015, 46(5): 2143-2153. DOI:10.3892/ijo.2015.2907. ［11］ Stein U, Burock S, Herrmann P, et al. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis［J］. PLoS One, 2012, 7(11): e49249. DOI:10.1371/journal.pone.0049249. ［12］ Schmid F, Burock S, Klockmeier K, et al. SNPs in the coding region of the metastasisinducing gene MACC1 and clinical outcome in colorectal cancer［J］. Mol Cancer, 2012, 11: 49. DOI:10.1186/1476-4598-11-49. ［13］ Kawamura M, Saigusa S, Toiyama Y, et al. Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy［J］. Anticancer Res, 2012, 32(4): 15271531. ［14］ Lang AH, GellerRhomberg S, Winder T, et al. A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients［J］. BMC Cancer, 2012, 12: 20. DOI:10.1186/1471-2407-12-20. ［15］ Shirahata A, Shinmura K, Kitamura Y, et al. MACC1 as a marker for advanced colorectal carcinoma［J］. Anticancer Res, 2010, 30(7): 2689-2692. ［16］ Wang L, Wu Y, Lin L, et al. Metastasisassociated in colon cancer1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion［J］. Int J Cancer, 2013, 133(6): 1419-1430. DOI:10.1002/ijc.28140. ［17］ Ge SH, Wu XJ, Wang XH, et al. Overexpression of metastasisassociated in colon cancer1 (MACC1) associates with better prognosis of gastric cancer patients［J］. Chin J Cancer Res, 2011, 23(2): 153-159. DOI:10.1007/s11670-011-0153-9. ［18］ Shirahata A, Sakata M, Kitamura Y, et al. MACC1 as a marker for peritonealdisseminated gastric carcinoma［J］. Anticancer Res, 2010, 30(9): 3441-3444. ［19］王妮娜, 谢剑明, 郑大勇, 等. 稳定表达MACC1的胃癌BGC823/pBaBbpuroMACC1细胞株的建立及其肿瘤相关基因的研究基因［J］. 南方医科大学学报, 2012, 32(3): 312-316. DOI: CNKI:44-1627/R.20120307.1708.024. ［20］ Qiu J, Huang P, Liu Q, et al. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma［J］. J Transl Med, 2011, 9: 166. DOI:10.1186/1479-5876-9-166. ［21］ Yang YP, Qu JH, Chang XJ. High intratumoral metastasisassociated in colon cancer1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma［J］. J Transl Med, 2013, 11: 41. DOI:10.1186/1479-5876-11-41. ［22］ Gao J, Ding F, Liu Q, et al. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9［J］. Mol Cell Biochem, 2013, 376(1-2): 21-32. DOI:10.1007/s11010-012-1545-y. ［23］ Qu JH, Chang XJ, Lu YY, et al. Overexpression of metastasisassociated in colon cancer 1 predicts a poor outcome of hepatitis B virusrelated hepatocellular carcinoma［J］. World J Gastroenterol, 2012, 18(23): 29953003. DOI:10.3748/wjg.v18.i23.2995. ［24］ Shirahata A, Fan W, Sakuraba K, et al. MACC1 as a marker for vascular invasive hepatocellular carcinoma［J］. Anticancer Res, 2011, 31(3): 777-780. ［25］丁飞虎, 高洁, 韩少山, 等. MACC1蛋白在肝细胞癌中的表达水平及其与患者预后的关系［J］. 华中科技大学学报: 医学版, 2013, 42(4): 464-468. DOI:10.3870/j.issn.1672-0741.2013.04.021. ［26］ Chundong G, Uramoto H, Onitsuka T, et al. Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis［J］. Anticancer Res, 2011, 31(4): 1141-1145. ［27］ Shimokawa H, Uramoto H, Onitsuka T, et al. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence［J］. J Thorac Cardiovasc Surg, 2011, 141(4): 895-898. DOI:10.1016/j.jtcvs.2010.09.044. ［28］杨淑慧, 龙摇敏, 王摇希, 等. MACC1基因siRNA对肺癌SBC5细胞增殖和迁移的影响［J］. 现代肿瘤医学, 2011, 19(4):633-636. DOI:10.3969/j.issn.16724992.2011.04.04. ［29］胡兴胜, 付曦, 文世民, 等. MACC1和cmet在非小细胞肺癌中的表达及其预后价值［J］. 中国肺癌杂志, 2012, 15(7): 399-403. DOI:10.3779/j.issn.10093419.2012.07.02. ［30］ Zhang R, Shi H, Chen Z, et al. Effects of metastasisassociated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR3 cells［J］. J Exp Clin Cancer Res, 2011, 30: 83. DOI:10.1186/1756-9966-30-83. ［31］张瑞涛，史惠蓉，黄好亮, 等. MACC1、HGF和Cmet蛋白在卵巢上皮性癌中的表达及其意义［J］. 南方医科大学学报, 2011, 31(9): 1551-1555.

[1]	Chu Xuelei, Mao Yun, Xue Peng, Li Linlu, Chen Meichi, Yuan Chunsheng, Qin Xiaoyan, Zhu Shijie. Effects of chemotherapy dose intensity on short-term efficacy in patients with advanced colon cancer： a study based on real-world data [J]. Journal of International Oncology, 2022, 49(7): 408-415.
[2]	Laibijiang Wusiman, Cao Bowei, Zhang Wenbin, Gao Hua. Effects of exogenous AGR2 on the proliferation and invasion abilities of colon cancer cells [J]. Journal of International Oncology, 2022, 49(2): 73-78.
[3]	Li Qianqian, Zhu Xiaodi, Zhao Ronglan, Peng Xiaoxiang. Role of P2X7 receptor in colon cancer progression [J]. Journal of International Oncology, 2021, 48(4): 250-253.
[4]	Zhou Huiping, Li Yuhua, Wang Yuhui, Su Yilong, Yang Yingying, Xu Xiaotian, Duan Xiaoqun. Preventive and therapeutic effects of common plant drugs on colon cancer and its mechanism [J]. Journal of International Oncology, 2020, 47(1): 51-55.
[5]	Zhao Gaochuan, Chen Qingqi, Pang Li, Cheng Zheng, Mai Fangqi. Serum levels and clinical significances of miR-205 and miR-221 in patients with colon cancer [J]. Journal of International Oncology, 2019, 46(9): 526-530.
[6]	HUANG Jiang, ZHANG Sheng-Jun, BAI Li-Jie, CHANG Qi. Relationship between the decrease of serum level of carcinoembryonic antigen during perioperative period and the prognosis in patients with colon cancer [J]. Journal of International Oncology, 2017, 44(8): 662-667.
[7]	Qiao Yinbiao, Yang Bo. Research progress of HGF/c-MET signaling pathway inhibitors in antipancreatic cancer [J]. Journal of International Oncology, 2017, 44(4): 304-306.
[8]	黄虞，杜冀晖，龚慧，王秀，王磊，李一凡. miR-92a promotes colorectal cancer cell proliferation by regulation of KLF4 gene expression [J]. Journal of International Oncology, 2017, 44(11): 812-818.
[9]	Wan Lijuan, Chen Mingwei. Relationship between insulin resistance related factors and colon cancer stem cells [J]. Journal of International Oncology, 2017, 44(10): 790-793.
[10]	GAN Ya-Ping, GUO Xiao-Hua, ZHANG Jun-Yu, XU Qing-Qing, WU Jiang, WANG Ren-Yong, QIU Min, JIANG Ru-Gang, LIU Fu-Xing, NING Zhi-Feng. Construction of colonic cancer drugresistant cell line COLO and its relationship with tumor stem cells [J]. Journal of International Oncology, 2016, 43(8): 646-650.
[11]	Wang Jianxun*, Zeng Tian, Zhang Peng, Wang Zhigang, Lei Hailu.. Effects of tumor suppressor NDRG2 gene on proliferation and invasive ability of colon cancer cell line SW620 [J]. Journal of International Oncology, 2016, 43(6): 401-404.
[12]	Zhao Xia, Zhang Bingxin, Zheng Shujun, Li Lin, Guo Jianmei, Ma Xudong, Jia Xihua. Expression and clinical significance of Apaf-1 and AEG-1 in colonic carcinoma [J]. Journal of International Oncology, 2015, 42(7): 508-511.
[13]	YANG Tian-Ning, ZHAO Da, MA Shou-Cheng, GUAN Quan-Lin. Meta-analysis of the association between GSTT1 and the susceptibility to colorectal cancer among Chinese population [J]. Journal of International Oncology, 2015, 42(10): 743-746.
[14]	Cui Yunfu, Hao Tao, Wang Ronghua, Li Baosong, Ma Chong, Fan Peng. Construction and inhibitory effect of microRNA expression vector targeting survivin on proliferation of human colorectal carcinoma HT-29 cells [J]. Journal of International Oncology, 2015, 42(1): 22-26.
[15]	DAN Chan-Chan, SHI Liang-Rong, DING Mei-Qian, ZHU Yi-Bei, XU Bin, JIANG Jing-Ting, WU Chang-Ping. The research of antitumor activities in vitro of DCs loading antigen prouced by radiofrequency ablation of tumor combined with CIK cells [J]. Journal of International Oncology, 2014, 41(6): 471-475.